Dual-Time-Point 18F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis

alexandrossfakianakis shared this article with you from Inoreader Dual-Time-Point 18F-FDG PET/CT for Differentiating a Chest Wall Hemangioma From a Malignant Metastasis via Clinical Nuclear Medicine - Published Ahead-of-Print Dual-time-point 18F-flluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) can be used to differentiate benign vascular tumors from other malignant growths. We present the case of a 70-year-old woman with a history of cervical carcinoma who was referred for PET/CT to examine a left chest wall tumor noted on CT, which involved the adjacent rib and pleura, thus raising the suspicion of metastasis. The chest wall tumor demonstrated moderate FDG uptake and further decreased uptake at the delayed-phase scanning, corresponding to biodistribution of FDG in the blood pool. These findings indica ted a benign hemangioma rather than a metastasis. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.